Literature DB >> 30567843

Phf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL.

Agnieszka A Wendorff1, S Aidan Quinn1,2, Marissa Rashkovan1, Chioma J Madubata3, Alberto Ambesi-Impiombato1, Mark R Litzow4, Martin S Tallman5, Elisabeth Paietta6, Maddalena Paganin7, Giuseppe Basso7,8, Julie M Gastier-Foster9,10,11,12, Mignon L Loh13,14, Raul Rabadan3,15, Pieter Van Vlierberghe16,17, Adolfo A Ferrando18,2,3,19.   

Abstract

The plant homeodomain 6 gene (PHF6) is frequently mutated in human T-cell acute lymphoblastic leukemia (T-ALL); however, its specific functional role in leukemia development remains to be established. Here, we show that loss of PHF6 is an early mutational event in leukemia transformation. Mechanistically, genetic inactivation of Phf6 in the hematopoietic system enhances hematopoietic stem cell (HSC) long-term self-renewal and hematopoietic recovery after chemotherapy by rendering Phf6 knockout HSCs more quiescent and less prone to stress-induced activation. Consistent with a leukemia-initiating tumor suppressor role, inactivation of Phf6 in hematopoietic progenitors lowers the threshold for the development of NOTCH1-induced T-ALL. Moreover, loss of Phf6 in leukemia lymphoblasts activates a leukemia stem cell transcriptional program and drives enhanced T-ALL leukemia-initiating cell activity. These results implicate Phf6 in the control of HSC homeostasis and long-term self-renewal and support a role for PHF6 loss as a driver of leukemia-initiating cell activity in T-ALL. SIGNIFICANCE: Phf6 controls HSC homeostasis, leukemia initiation, and T-ALL leukemia-initiating cell self-renewal. These results substantiate a role for PHF6 mutations as early events and drivers of leukemia stem cell activity in the pathogenesis of T-ALL.This article is highlighted in the In This Issue feature, p. 305. ©2018 American Association for Cancer Research.

Entities:  

Year:  2018        PMID: 30567843      PMCID: PMC6425751          DOI: 10.1158/2159-8290.CD-18-1005

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  18 in total

1.  Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials.

Authors:  Yueh-Chwen Hsu; Tsung-Chih Chen; Chien-Chin Lin; Chang-Tsu Yuan; Chia-Lang Hsu; Hsin-An Hou; Chein-Jun Kao; Po-Han Chuang; Yu-Ren Chen; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Blood Adv       Date:  2019-08-13

2.  PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia.

Authors:  Helen M McRae; Alexandra L Garnham; Yifang Hu; Matthew T Witkowski; Mark A Corbett; Mathew P Dixon; Rose E May; Bilal N Sheikh; William Chiang; Andrew J Kueh; Tan A Nguyen; Kevin Man; Renee Gloury; Brandon J Aubrey; Antonia Policheni; Ladina Di Rago; Warren S Alexander; Daniel H D Gray; Andreas Strasser; Edwin D Hawkins; Stephen Wilcox; Jozef Gécz; Axel Kallies; Matthew P McCormack; Gordon K Smyth; Anne K Voss; Tim Thomas
Journal:  Blood       Date:  2019-02-12       Impact factor: 22.113

Review 3.  The Role of PHF6 in Hematopoiesis and Hematologic Malignancies.

Authors:  Yusra A Eisa; Ying Guo; Feng-Chun Yang
Journal:  Stem Cell Rev Rep       Date:  2022-08-26       Impact factor: 6.692

4.  Genomic landscape of T-cell lymphoblastic lymphoma.

Authors:  Zhaoming Li; Yue Song; Mingzhi Zhang; Yiming Wei; Hang Ruan
Journal:  Chin J Cancer Res       Date:  2022-04-30       Impact factor: 4.026

5.  Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair.

Authors:  Tsung-Chih Chen; Chi-Yuan Yao; Yu-Ren Chen; Chang-Tsu Yuan; Chien-Chin Lin; Yueh-Chwen Hsu; Po-Han Chuang; Chein-Jun Kao; Yi-Hung Li; Hsin-An Hou; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Oncogene       Date:  2022-01-28       Impact factor: 8.756

Review 6.  The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.

Authors:  Francesca Gianni; Laura Belver; Adolfo Ferrando
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

7.  Transgenic mice with an R342X mutation in Phf6 display clinical features of Börjeson-Forssman-Lehmann Syndrome.

Authors:  Raies Ahmed; Shihab Sarwar; Jinghua Hu; Valérie Cardin; Lily R Qiu; Gerardo Zapata; Lucianne Vandeleur; Keqin Yan; Jason P Lerch; Mark A Corbett; Jozef Gecz; David J Picketts
Journal:  Hum Mol Genet       Date:  2021-05-12       Impact factor: 6.150

8.  Modeling NOTCH1 driven T-cell Acute Lymphoblastic Leukemia in Mice.

Authors:  Agnieszka A Wendorff; Adolfo A Ferrando
Journal:  Bio Protoc       Date:  2020-05-20

9.  Functional mapping of PHF6 complexes in chromatin remodeling, replication dynamics, and DNA repair.

Authors:  Silvia Alvarez; Ana C da Silva Almeida; Robert Albero; Mayukh Biswas; Angelica Barreto-Galvez; Thomas S Gunning; Anam Shaikh; Tomas Aparicio; Agnieszka Wendorff; Erich Piovan; Pieter Van Vlierberghe; Steven Gygi; Jean Gautier; Advaitha Madireddy; Adolfo A Ferrando
Journal:  Blood       Date:  2022-06-09       Impact factor: 25.476

Review 10.  Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis.

Authors:  Masayuki Yamashita; Paul V Dellorusso; Oakley C Olson; Emmanuelle Passegué
Journal:  Nat Rev Cancer       Date:  2020-05-15       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.